Imetelstat (Rytelo): a promising treatment for adults with lower-risk MDS and transfusion-dependent anemia
Ann Med Surg (Lond)
.
2024 Oct 28;86(12):6918-6920.
doi: 10.1097/MS9.0000000000002698.
eCollection 2024 Dec.
Authors
Iqra Furqan Ahmed
1
,
Ayman Tahseen
2
,
Marc Fakhoury
3
,
Muzzamil Hussain Shaik
4
,
Fenil Gandhi
5
,
Christopher Belletieri
6
Affiliations
1
Department of Internal Medicine, Liaquat National Hospital and Medical College Karachi, Pakistan.
2
Department of Internal Medicine, Karachi Medical and Dental College, Karachi, Pakistan.
3
Department of Medicine, Saint Joseph University of Beirut, Lebanon.
4
Department of Internal Medicine, New Vision University, Tbilisi, Georgia.
5
Department of Family Medicine, PGY2, Lower Bucks Hospital, Bristol, PA, USA.
6
Department of Family Medicine, Program Director, Lower Bucks Hospital, Bristol, PA, USA.
PMID:
39649872
PMCID:
PMC11623864
DOI:
10.1097/MS9.0000000000002698
No abstract available
Publication types
Editorial